About the Authors
- Gerard H. Bode
-
Affiliation Department of Neuroscience, School for Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands
- Karin E. Pickl
-
Affiliation HEALTH—Institute for Biomedicine and Health Sciences, Joanneum Research Forschungsgesellschaft m.b.H, Graz, Austria
- Maria Sanchez-Purrà
-
Affiliation Grup d'Enginyeria de Materials (GEMAT), Institut Químic de Sarrià, Universitat Ramon Llull, Barcelona, Spain
- Berta Albaiges
-
Affiliation Grup d'Enginyeria de Materials (GEMAT), Institut Químic de Sarrià, Universitat Ramon Llull, Barcelona, Spain
- Salvador Borrós
-
Affiliation Grup d'Enginyeria de Materials (GEMAT), Institut Químic de Sarrià, Universitat Ramon Llull, Barcelona, Spain
- Andy J. G. Pötgens
-
Affiliation AplaGen GmbH, Arnold-Sommerfeld-Ring 2, Baesweiler, Germany
- Christoph Schmitz
-
Affiliation Department of Neuroanatomy, Ludwig-Maximilians-University of Munich, Munich, Germany
- Frank M. Sinner
-
Affiliation Medical University of Graz, Department of Internal Medicine, Division of Endocrinology and Metabolism, Graz, Austria
- Mario Losen
-
Affiliation Department of Neuroscience, School for Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands
- Harry W. M. Steinbusch
-
Affiliation Department of Neuroscience, School for Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands
- Hans-Georg Frank
-
Affiliations AplaGen GmbH, Arnold-Sommerfeld-Ring 2, Baesweiler, Germany, Department of Neuroanatomy, Ludwig-Maximilians-University of Munich, Munich, Germany
- Pilar Martinez-Martinez
-
* E-mail: p.martinez@maastrichtuniversity.nl
Affiliation Department of Neuroscience, School for Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands
- European NanoBioPharmaceutics Research Initiative
-
¶Membership of the European NanoBioPharmaceutics Research Initiative is listed in the Acknowledgments.
Competing Interests
Although one or more of the authors are employed by a commercial company, AplaGen GmbH, this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: ML FMS AJGP H-GF CS SB PM-M. Performed the experiments: GHB KEP BA MS-P. Analyzed the data: GHB KEP. Contributed reagents/materials/analysis tools: AJGP H-GF CS SB HWMS. Wrote the paper: GHB KEP ML PM-M.